CHICAGO, January 29, 2021 / PRNewswire / - HabitNu announced today that an affordable online diabetes prevention program is now available at Chicago new...
The Food and Drug Administration (FDA) has approved Zegalogue® (dasiglucagon) for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged...